Author:
Davids Joseph,Ashrafian Hutan
Publisher
Springer International Publishing
Reference73 articles.
1. Moyle W. The promise of technology in the future of dementia care. Nat Rev Neurol. 2019;15(6):353–9.
2. Johnston TH, Lacoste AMB, Visanji NP, Lang AE, Fox SH, Brotchie JM. Repurposing drugs to treat L-DOPA-induced dyskinesia in Parkinson’s disease. Neuropharmacology. 2019;147:11–27.
3. Belic M, Bobic V, Badza M, Solaja N, Duric-Jovicic M, Kostic VS. Artificial intelligence for assisting diagnostics and assessment of Parkinson’s disease: a review. Clin Neurol Neurosurg. 2019;105442:184.
4. Battista P, Salvatore C, Berlingeri M, Cerasa A, Castiglioni I. Artificial intelligence and neuropsychological measures: the case of Alzheimer’s disease. Neurosci Biobehav Rev. 2020;114:211–28.
5. Chiu PY, Wei CY. A history-based computerized questionnaire for the diagnosis of severity and subtypes of dementia: design and verify. Alzheimer Dement. 2019;15(7 Supplement):P688–P9.